44 results
ARS
2023 FY
MYGN
Myriad Genetics, Inc.
17 Apr 24
Annual report to shareholders
4:33pm
and implement multi-faceted programs to protect workers from exposure to blood-borne pathogens, including preventing or minimizing any exposure through needle
8-K
EX-10.1
guk8o
5 Oct 23
Departure of Directors or Certain Officers
8:30am
8-K
EX-10.1
zchlv
6 Jul 23
Entry into a Material Definitive Agreement
8:24am
ARS
lm1seonb
12 Apr 23
Annual report to shareholders
4:10pm
8-K
EX-10.1
m993ywbhqrd0rftr5uo6
27 Jul 22
Entry into a Material Definitive Agreement
4:11pm
8-K
EX-10.1
ppk8was8b0hacl8t
9 Feb 22
Departure of Directors or Certain Officers
5:00pm
10-KT
o91 4b8b2
16 Mar 21
Annual report (with FYE transition)
2:24pm
8-K
EX-10.1
lxq8ubwewuvp
23 Feb 21
Company Continues to Execute Strategic Transformation Plan
4:15pm
8-K
EX-10.1
kmio4nrzgn4v7l
12 May 20
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.2
8rkm6tgzdp
5 May 20
Myriad Genetics Reports Fiscal Third-Quarter 2020 Financial Results
4:18pm